UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Age and outcome with contemporary thrombolytic therapy : Results from the GUSTO-I trial

Circulation (New York, N.Y.), 1996-10, Vol.94 (8), p.1826-1833

1996

Volltextzugriff (PDF)

Stroke after thrombolysis : mortality and functional outcomes in the GUSTO-I trial

Circulation (New York, N.Y.), 1995-11, Vol.92 (10), p.2811-2818

1995

Volltextzugriff (PDF)

Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents. A comparison of TNK-tPA and rt-PA

European heart journal, 2001-12, Vol.22 (24), p.2253-2261

2001

Volltextzugriff (PDF)

Cost Effectiveness of Thrombolytic Therapy with Tissue Plasminogen Activator as Compared with Streptokinase for Acute Myocardial Infarction

The New England journal of medicine, 1995-05, Vol.332 (21), p.1418-1424

1995

Volltextzugriff (PDF)

Prognostic significance of the admission electrocardiogram in acute myocardial infarction

Journal of the American College of Cardiology, 1996-04, Vol.27 (5), p.1128-1132

1996

Volltextzugriff (PDF)

Early reinfarction after fibrinolysis: Experience from the Global Utilization of Streptokinase and Tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and Global Use of Strategies To Open occluded coronary arteries (GUSTO III) trials

Circulation (New York, N.Y.), 2001-09, Vol.104 (11), p.1229-1235

2001

Volltextzugriff (PDF)

Correlation of angiographic findings and right (V 1 to V 3) versus left (V 4 to V 6) precordial ST-segment depression in inferior wall acute myocardial infarction

The American journal of cardiology, 1999-01, Vol.83 (2), p.143-148

1999

Volltextzugriff (PDF)

Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial

Circulation (New York, N.Y.), 1993-01, Vol.87 (1), p.53-58

1993

Volltextzugriff (PDF)

Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis results from GUSTO-I

Circulation (New York, N.Y.), 1998-03, Vol.97 (8), p.757-764

1998

Volltextzugriff (PDF)

Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: Mechanism of the “smoker's paradox” from the GUSTO-I trial, with angiographic insights

Journal of the American College of Cardiology, 1995-11, Vol.26 (5), p.1222-1229

1995

Volltextzugriff (PDF)

Prediction of the extent and severity of left ventricular dysfunction in anterior acute myocardial infarction by the admission electrocardiogram

The American heart journal, 2001-06, Vol.141 (6), p.915-924

2001

Volltextzugriff (PDF)

Selection of thrombolytic therapy for individual patients: Development of a clinical model

The American heart journal, 1997-06, Vol.133 (6), p.630-639

1997

Volltextzugriff (PDF)

Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: Experience from the GUSTO-I Trial

The American heart journal, 1999-09, Vol.138 (3), p.493-499

1999

Volltextzugriff (PDF)

Admission clinical and electrocardiographic characteristics predicting an increased risk for early reinfarction after thrombolytic therapy

The American heart journal, 1998-05, Vol.135 (5), p.805-812

1998

Volltextzugriff (PDF)

Prognostic significance of precordial ST segment depression on admission electrocardiogram in patients with inferior wall myocardial infarction

Journal of the American College of Cardiology, 1996-08, Vol.28 (2), p.313-318

1996

Volltextzugriff (PDF)

Variations in Patient Management and Outcomes for Acute Myocardial Infarction in the United States and Other Countries: Results From the GUSTO Trial

JAMA : the journal of the American Medical Association, 1995-05, Vol.273 (20), p.1586

Van de Werf, Frans

1995

Volltextzugriff (PDF)

Comparison of primary coronary angioplasty versus thrombolysis in patients with ST-segment elevation acute myocardial infarction and grade II and grade III myocardial ischemia on the enrollment electrocardiogram

The American journal of cardiology, 2001-10, Vol.88 (8), p.842-847

2001

Volltextzugriff (PDF)

Antecedent angina pectoris predicts worse outcome after myocardial infarction in patients receiving thrombolytic therapy: Experience gleaned from the international tissue plasminogen activator/streptokinase mortality trial

Journal of the American College of Cardiology, 1992-07, Vol.20 (1), p.36-41

1992

Volltextzugriff (PDF)

Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction : Review of ocular hemorrhage incidence and location in the GUSTO-I trial

Journal of the American College of Cardiology, 1997-12, Vol.30 (7), p.1606-1610

1997

Volltextzugriff (PDF)

The Prognostic Implications of Negative T Waves in the Leads with ST Segment Elevation on Admission in Acute Myocardial Infarction

Cardiology, 1999-01, Vol.92 (2), p.121-127

1999

Volltextzugriff (PDF)

Acute myocardial infarction in the young—the role of smoking

European heart journal, 1995-03, Vol.16 (3), p.313-316

1995

Volltextzugriff (PDF)

Treatment of reinfarction after Thrombolytic therapy for acute myocardial infarction : An analysis of outcome and treatment choices in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for occluded Coronary Arteries (GUSTO I) and Assessment of the Safety of a New Thrombolytic (ASSENT 2) studies

Circulation (New York, N.Y.), 2001-02, Vol.103 (7), p.954-960

2001

Volltextzugriff (PDF)

Abnormal Q waves on the admission electrocardiogram of patients with first acute myocardial infarction: Prognostic implications

Clinical cardiology (Mahwah, N.J.), 1997-05, Vol.20 (5), p.477-481

1997

Volltextzugriff (PDF)

Rapid resolution of ST elevation and prediction of clinical outcome in patients undergoing thrombolysis with alteplase (recombinant tissue-type plasminogen activator): results of the Israeli Study of Early Intervention in Myocardial Infarction

British Heart Journal, 1990-10, Vol.64 (4), p.241-247

1990

Volltextzugriff (PDF)

Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial

The Lancet (British edition), 1999-08, Vol.354 (9180), p.716-722

Van de Werf, Frans

1999

Volltextzugriff (PDF)

1 – 25 von 262

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(230)
Mit Volltextzugriff
(219)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(164)
Life Sciences & Biomedicine
(151)
Humans
(138)
Female
(102)
Biological And Medical Sciences
(88)
Medical Sciences
(86)
Male
(84)
Middle Aged
(77)
Aged
(73)
Cardiac & Cardiovascular Systems
(60)
Cardiovascular System & Cardiology
(60)
Myocardial Infarction - Drug Therapy
(41)
Risk Factors
(33)
Adult
(31)
Pharmacology. Drug Treatments
(31)
Thrombolytic Therapy
(28)
Treatment Outcome
(28)
Animals
(27)
Myocardial Infarction - Mortality
(27)
Oncology
(27)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Age and outcome with contemporary thrombolytic therapy : Results from the GUSTO-I trial

Stroke after thrombolysis : mortality and functional outcomes in the GUSTO-I trial

Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents. A comparison of TNK-tPA and rt-PA

Cost Effectiveness of Thrombolytic Therapy with Tissue Plasminogen Activator as Compared with Streptokinase for Acute Myocardial Infarction

Prognostic significance of the admission electrocardiogram in acute myocardial infarction

Early reinfarction after fibrinolysis: Experience from the Global Utilization of Streptokinase and Tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and Global Use of Strategies To Open occluded coronary arteries (GUSTO III) trials

Correlation of angiographic findings and right (V 1 to V 3) versus left (V 4 to V 6) precordial ST-segment depression in inferior wall acute myocardial infarction

Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial

Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis results from GUSTO-I

Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: Mechanism of the “smoker's paradox” from the GUSTO-I trial, with angiographic insights

Prediction of the extent and severity of left ventricular dysfunction in anterior acute myocardial infarction by the admission electrocardiogram

Selection of thrombolytic therapy for individual patients: Development of a clinical model

Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: Experience from the GUSTO-I Trial

Admission clinical and electrocardiographic characteristics predicting an increased risk for early reinfarction after thrombolytic therapy

Prognostic significance of precordial ST segment depression on admission electrocardiogram in patients with inferior wall myocardial infarction

Variations in Patient Management and Outcomes for Acute Myocardial Infarction in the United States and Other Countries: Results From the GUSTO Trial

Comparison of primary coronary angioplasty versus thrombolysis in patients with ST-segment elevation acute myocardial infarction and grade II and grade III myocardial ischemia on the enrollment electrocardiogram

Antecedent angina pectoris predicts worse outcome after myocardial infarction in patients receiving thrombolytic therapy: Experience gleaned from the international tissue plasminogen activator/streptokinase mortality trial

Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction : Review of ocular hemorrhage incidence and location in the GUSTO-I trial

The Prognostic Implications of Negative T Waves in the Leads with ST Segment Elevation on Admission in Acute Myocardial Infarction

Acute myocardial infarction in the young—the role of smoking

Abnormal Q waves on the admission electrocardiogram of patients with first acute myocardial infarction: Prognostic implications

Rapid resolution of ST elevation and prediction of clinical outcome in patients undergoing thrombolysis with alteplase (recombinant tissue-type plasminogen activator): results of the Israeli Study of Early Intervention in Myocardial Infarction

Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial

Suchergebnisse filtern